Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite® during acute haemorrhage

British Journal of Anaesthesia

Volumn 112, Issue 3, 2014, Pages 514-520

  Gauss, T ^a,b   Hamada, S ^a,b   Jurcisin, I ^a   Dahmani, S ^c,d   Boudaoud, L ^a   Mantz, J ^a,b,d   Paugam Burtz, C ^a,b,d  

^a BEAUJON HOSPITAL   (France)

^b Association Groupe Traumabase   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

blood coagulation disorders; haemorrhage; injuries; point of care systems; surgical blood loss

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL DEVICE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE DEVICE; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD;

BLOOD COAGULATION DISORDERS; HAEMORRHAGE; INJURIES; POINT-OF-CARE SYSTEMS; SURGICAL BLOOD LOSS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOOD COAGULATION TESTS; EQUIPMENT DESIGN; ERYTHROCYTE TRANSFUSION; FEMALE; HEMODYNAMICS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PARTIAL THROMBOPLASTIN TIME; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; RABBITS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84896880154     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet384     Document Type: Article

References (28)

1. Shander A. Financialand clinical outcomes associatedwith surgical bleeding complications. Surgery 2007; 142: S20-5
2. Lenoir B, Merckx P, Paugam-Burtz C, et al. Individual probability of allogeneic erythrocyte transfusion in elective spine surgery: the predictive model of transfusion in spine surgery. Anesthesiology 2009; 110: 1050-60
3. Walsh TS, Palmer J, Watson D, et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2011; 108: 63-71
4. Sauaia A, Moore FA, Moore EE, et al. Epidemiologyoftrauma deaths: a reassessment. J Trauma 1995; 38: 185-93
5. MacLeod JBA, Lynn M, Mc Kenney MG, Cohn SM, Murtha M. Earlycoa-gulopathy predicts mortality in trauma. J Trauma 2003; 55: 39-44
6. Gunter OL Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008; 65: 527-34
7. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet tored bloodcell ratios improvesoutcomein 466massive-ly transfused civilian trauma patients. Ann Surg 2008; 248: 447-58
8. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusionareassociatedwith mortalityinseveremultipleinjury:a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 2008; 95: 112-9
9. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66: 41-8; discussion 48-9
10. Mohan D, Angus DC. Thought outside the box: intensive care unit freakonomics and decision making in the intensive care unit. Crit Care Med 2010; 38: S637-41
11. Toulon P, Ozier Y, Ankri A, Fléron M-H, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009; 101: 394-401
12. Hasenkam JM, Knudsen L, Kimose HH, et al. Practicabilityof patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) usingaportable whole blood monitor. A pilot investigation. Thromb Res 1997; 85: 77-82
13. Vacas M, Lafuente PJ, Cuesta S, Iriarte JA. Comparative study of a portable monitor for prothrombin time determination, Coaguchek, with three systems for control of oral anticoagulant treatment. Haemostasis 1998; 28: 321-8
14. Bauman ME, Black KL, Massicotte MP, et al. Accuracyof the Coagu-Chek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-103
15. Jensen E, Hyltoft P. Hemochronw Jr. Signature Whole Blood Micro-coagulation System manufactured by ITC, USA test for Prothrom-bine Time, PT (INR). Copenhagen, 2004
16. Moore GW, Henley A, Cotton SS, Tugnait S, Rangarajan S. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting. Blood Coagul Fibrinolysis 2007; 18: 287-92
17. Maddox JM, Bogo PH, McGregor E, Pippard MJ, Kerr R. Quality assurance for point-of-care testing of oral anticoagulation: a large-scale evaluation of the Hemochron Junior Signature Micro-coagulation System. Int J Lab Hematol 2009; 31: 142-50
18. Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-8
19. David JS, Levrat A, Inaba K, et al. Utility of a point-of-care device for rapid determination ofprothrombin time in trauma patients: apre-liminary study. J Trauma Acute Care Surg 2012; 72: 703-7
20. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52
21. Herbstreit F, Winter EM, Peters J, Hartmann M. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests. Anaesthesia 2010; 65: 44-9
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10
23. Myles PS, Cui JI. Using the Bland Altman method to measure agreement with repeated measures. Br J Anaesth 2007; 99: 309-11
24. w Jr II Signature) with low dose heparin therapy. Anaesthesia 2009; 64: 430-4
25. Ho AM-H, Lee A, Ling E, Daly A, Teoh K, Warkentin TE. Agreements between the prothrombin times of blood treated invitro with hepar- inaseduringcardiopulmonarybypass(CPB)andbloodsampledafter CPB and systemic protamine. Anesth Analg 2003; 96: 15-20
26. Shermock KM, Streiff MB, Pinto BL, Kraus P, Pronovost PJ. Novel analysis of clinically relevant diagnostic errorsin point-of-care devices. J Thromb Haemost 2011; 9: 1769-75
27. w assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011; 107: 378-87
28. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47